作者：子超@宠业家 【写在前面】 宠业家「融资栏目」，为关注宠物投融资动态的朋友，带来行业内最新宠物公司投融资事件跟踪报道。 【融资事件】 近日，南京派特美生科技有限公司顺利完成新一轮融资，参投机构包括勤智资本。 此次是派特美生成立以来第二次获得资本青睐，其首次融资就得到了江北新区科技投资集团有限公司的支持，充分体现了该新区科创生态对优质宠物医药 企业的吸引力和培育力。 【关于派特美生】 派特美生是江北新区重点培育的高科技动保企业，专注于宠物创新药物研发，契合新区宠物健康产业集聚区的布局规划。公司创始人李轶来自药石科技创 始团队，拥有深厚的生物医药行业经验，2023年8月在江北新区创办该公司，短短两年内实现两次融资，成长势头迅猛。 【关于勤智资本】 勤智资本是一家专注于生物医药和医疗健康领域的创投机构，成立于2015年10月。 目前，公司正全力打造全国首家高标准一站式宠物健康创新技术服务平台，拥有10余个在研项目，其中4个为目标一类创新药项目，研发实力位居行业前 列，有效弥补了国产宠物创新药的短板，与新区推动宠物医药自主化的发展目标高度契合。 该公司以"投资回归实业、资本服务产业"为理念，重点投资创新药、细胞 ...

Industry Overview - The pet medical market is transitioning from a niche sector to a competitive arena, driven by the increasing demand for pet healthcare as pets are considered family members [1][2] - The pet medical market is projected to account for approximately 28% of total pet consumption in urban China by 2024, with a market size of around 800 billion yuan [2] Company Involvement - Numerous listed companies and large pharmaceutical firms are entering the pet medicine sector, including Hai Zheng Pharmaceutical, Huadong Medicine, and Reap Bio [2][3] - Hai Zheng Dongbao, a subsidiary of Hai Zheng Pharmaceutical, has become a leading brand in the domestic pet medicine market, focusing on deworming drugs and vaccines [3] Market Potential - The pet medicine market is primarily composed of deworming drugs, skin disease medications, and vaccines, with deworming drugs accounting for about 60% of the market share [4] - There is a significant demand for medications targeting elderly pets, chronic diseases, and tumors, indicating a potential growth area for the pet medicine industry [5][6] R&D and Innovation - The R&D costs for pet medicines are significantly lower than for human medicines, with pet innovation drugs typically costing between 20 million to 30 million yuan [2][5] - Hai Zheng Dongbao plans to leverage its human medicine resources to enhance its pet medicine R&D capabilities, aiming to reduce costs and risks [3][6] Vaccine Development - The domestic pet vaccine market is experiencing accelerated progress in local alternatives, with the first domestically approved cat trivalent vaccine set to launch in January 2024 [7] - By mid-2025, 11 domestic cat trivalent vaccines are expected to be available, with domestic vaccines capturing a 25% market share [7][8] Future Outlook - The aging pet population is anticipated to drive the demand for pet healthcare services, with over 30 million pets expected to enter middle age in the next three years [5] - Companies are focusing on developing a product matrix that includes both vaccines and chemical drugs to meet the growing market needs [8]

Group 1: Employment Trends - In the first half of the year, 6.95 million new urban jobs were created, achieving 58% of the annual target, indicating overall stability in the employment situation [1] - The demand for talent in emerging industries and modern service sectors is increasing, reflecting a significant impact of industrial development on employment [1][3] - The shift from "demographic dividend" to "talent dividend" is evident, with a growing demand for high-tech and high-value-added positions [3] Group 2: Emerging Industries - The demand for composite talents in fields such as humanoid robotics and low-altitude economy is surging, with job postings in humanoid robots, new materials, and smart hardware increasing by 398.1%, 72.1%, and 50.3% year-on-year, respectively [2] - Companies like EX Robotics and WoFei ChangKong are actively seeking talent in mechanical automation, artificial intelligence, and supply chain management [2] Group 3: Service Sector Opportunities - The pet medicine sector is experiencing a talent shortage, with companies like Jiangxi Ruide Pharmaceutical Co., Ltd. needing professionals in product development and analysis, constituting about 30% of their workforce [4] - The modern service industry is witnessing rapid growth in job demand, particularly in pet services, automotive aftermarket, elderly care, and online life services, with pet services leading at a 72.2% increase in job postings [4] Group 4: Policy Support - The government is implementing policies to support employment growth along the industrial chain, including a series of incentives and skills training programs [5][6] - The Ministry of Human Resources and Social Security has introduced measures that have effectively reduced labor costs for enterprises by over 90 billion yuan through unemployment insurance rate reductions and other subsidies [6] - Continuous support for vocational skills training in key sectors is planned, with a target of subsidizing over 10 million training sessions annually for the next three years [6]

Summary of Conference Call Notes Industry Overview - The conference focused on the pet food industry, highlighting the strong growth momentum and the rise of domestic brands in the market [3][20]. - The competitive landscape shows a shift with domestic brands gaining market share, particularly in the pet food sector [3][20]. Key Points and Arguments - **Profit Growth**: Companies like Lusi and Peddy reported profit growth rates of 45%, 69%, and 15% respectively, indicating a robust performance across the sector [2]. - **Domestic Market Performance**: The domestic market for pet food is thriving, with brands like Guobao and Zhongchong showing significant revenue increases. Guobao's domestic revenue reached 3.55 billion, a 24% year-on-year growth, while Zhongchong's revenue was 1.414 billion, growing by 30.3% [6][9]. - **Market Share Dynamics**: In the top 20 pet food brands, foreign brands still hold 6 to 7 positions, but domestic brands are rapidly rising, especially during major sales events like Double Eleven [4][3]. - **Mainstream Products**: The pet food market is primarily driven by staple foods, which account for over 80% of the market share, while snacks only represent about 8% [7]. - **High Profit Margins**: Staple foods generally have higher profit margins compared to snacks due to lower labor requirements in production [8]. Emerging Trends - **Domestic Brand Growth**: There is a strong expectation for domestic brands to continue growing, with projections suggesting Guobao could achieve over 20% growth in the next few years [9]. - **Impact of Tariffs**: Changes in tariffs, particularly from the U.S., are creating opportunities for domestic brands to fill the gap left by foreign imports, especially in the high-end market segment [12][14]. - **Export Growth**: The pet food export market is also expanding, with a 20% growth reported in 2024, driven mainly by snack products [15]. Additional Insights - **Product Innovation**: Companies are focusing on product innovation and marketing strategies to enhance their market presence, with positive feedback on new product lines like broth series [11]. - **Investment Opportunities**: The report highlights Zhongchong and Guobao as key players to watch, with Zhongchong's U.S. factory providing a competitive edge in the export market [16][17]. - **Pharmaceutical Sector**: The pet pharmaceutical market is also noted as an area of interest, with companies like Ruipu Biological showing promise in pet medicine and supply chain management [20]. Conclusion - The pet food industry is experiencing a vibrant phase of growth, driven by domestic brands and changing market dynamics. The focus on staple foods, innovative products, and strategic responses to tariff changes are key factors contributing to this positive outlook [18][19].